These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37901160)

  • 1. Radiochemical and biological assessments of a PSMA-I&S cold kit for fast and inexpensive
    Fuscaldi LL; Sobral DV; Durante ACR; Mendonça FF; Miranda ACC; Salgueiro C; de Castiglia SG; Yamaga LYI; da Cunha ML; Malavolta L; de Barboza MF; Mejia J
    Front Chem; 2023; 11():1271176. PubMed ID: 37901160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
    Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
    J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Yılmaz B; Şahin S; Ergül N; Çolakoğlu Y; Baytekin HF; Sökmen D; Tuğcu V; Taşçı Aİ; Çermik TF
    Ann Nucl Med; 2022 Jul; 36(7):597-609. PubMed ID: 35426599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and preclinical evaluation of novel
    Kunert JP; Müller M; Günther T; Stopper L; Urtz-Urban N; Beck R; Wester HJ
    EJNMMI Res; 2023 Jan; 13(1):2. PubMed ID: 36645586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical translation of a PSMA inhibitor for
    Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
    Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of the [
    Fuscaldi LL; Sobral DV; Durante ACR; Mendonça FF; Miranda ACC; da Cunha ML; Malavolta L; Mejia J; de Barboza MF
    Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33918987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen.
    Mosayebnia M; Hajimahdi Z; Beiki D; Rezaeianpour M; Hajiramezanali M; Geramifar P; Sabzevari O; Amini M; Hatamabadi D; Shahhosseini S
    Bioorg Chem; 2020 Jun; 99():103743. PubMed ID: 32217372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
    Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD
    J Nucl Med; 2022 Nov; 63(11):1659-1664. PubMed ID: 35241483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Characterization of
    Bolzati C; Gobbi C; Ferro-Flores G; Turato S; Ocampo-Garcia B; Carpanese D; Marzano C; Spolaore B; Fracasso G; Rosato A; Meléndez-Alafort L
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer.
    Shimizu Y; Ando M; Watanabe H; Ono M
    Ann Nucl Med; 2024 Oct; 38(10):847-851. PubMed ID: 38976087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging and treatment of PSMA-positive prostate cancer with
    Jiao Y; Xu P; Luan S; Wang X; Gao Y; Zhao C; Fu P
    Nucl Med Biol; 2022; 104-105():28-37. PubMed ID: 34847481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and clinical translation of
    Vats K; Agrawal K; Sharma R; Sarma HD; Satpati D; Dash A
    Medchemcomm; 2019 Dec; 10(12):2111-2117. PubMed ID: 32190233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and Biological Evaluation of [
    Xiao D; Duan X; Gan Q; Zhang X; Zhang J
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33256058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, Biological Evaluation, and First-in-Human Single-Photon Emission Computed Tomography (SPECT) Study of
    Xiao D; Han P; Jiang Y; Duan X; Ruan Q; Zhang Z; Chen X; Zhang J
    ACS Pharmacol Transl Sci; 2024 May; 7(5):1335-1347. PubMed ID: 38751628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed Imaging Improves Lesion Detectability in [
    Berliner C; Steinhelfer L; Chantadisai M; Kroenke M; Koehler D; Pose R; Bannas P; Knipper S; Eiber M; Maurer T
    J Nucl Med; 2023 Jul; 64(7):1036-1042. PubMed ID: 37230531
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Xu X; Zhang J; Hu S; He S; Bao X; Ma G; Luo J; Cheng J; Zhang Y
    Nucl Med Biol; 2017 May; 48():69-75. PubMed ID: 28273495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Radiolabeling of Glu-Urea-Lys with
    Hatamabadi D; Joukar S; Shakeri P; Balalaie S; Yazdani A; Khoramjouy M; Mazidi SM; Kobarfard F; Mosayebnia M; Bozorgchami N; Ahmadi M; Ayyoubzadeh SM; Shahhosseini S
    Cancer Biother Radiopharm; 2023 Sep; 38(7):486-496. PubMed ID: 37578479
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Maurer T; Robu S; Schottelius M; Schwamborn K; Rauscher I; van den Berg NS; van Leeuwen FWB; Haller B; Horn T; Heck MM; Gschwend JE; Schwaiger M; Wester HJ; Eiber M
    Eur Urol; 2019 Apr; 75(4):659-666. PubMed ID: 29625755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Evaluation of a Novel High-Affinity Radioligand [
    Bezverkhniaia E; Kanellopoulos P; Abouzayed A; Larkina M; Oroujeni M; Vorobyeva A; Rosenström U; Tolmachev V; Orlova A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.